News＆Topics
Launch of the "MCI-iCONM Co-Creation Lab" for a Lesirient and Healthy Society
On February 25, iCONM announced the opening of the "MCI-iCONM Co-Creation Lab" within its facility, designed as a collaborative research space with Mitsui Chemicals, Inc. (MCI).
https://iconm.kawasaki-net.ne.jp/en/pdf/250225pressrelease_en.pdf
The kickoff meeting, held on February 12 and attended by key stakeholders only, featured Shingo Shibata, Executive Officer and Head of Research and Development at MCI, alongside Kazunori Kataoka, Center Director at iCONM. During this meeting, both leaders outlined their shared goals for collaboration and fostered a sense of unity among all project members.
Steering Committee Members for MCI-iCONM Co-Creation Lab
Back row from left:
Takanori Ichiki, iCONM Research Director (Co-Creation Research Leader); Kazunori Kataoka, iCONM Center Director; Shingo Shibata, MCI Center Executive of R&D Center; Hiroyasu Yamaoka, MCI R&D Planning & Coordination Div. General Manager; Hirokazu Awano, MCI R&D Planning & Coordination Div. Pharmaceutical Affairs Group Leader.
Front row from Left:
Takehiro Ichioka, iCONM IP Manager; Koji Nagai, iCONM Deputy Center Director; Yoshikazu Uehara, MCI Frontier Technology Center Senior Director; Eiji Watanabe, MCI Frontier Technology Center Manager (Co-Creation Project Leader).